Jason M. Hannon
Vorstandsvorsitzender bei MAINSTAY MEDICAL INTERNATIONAL
Vermögen: 46 819 $ am 30.04.2024
Profil
Jason M.
Hannon is currently the President, CEO & Executive Director at Mainstay Medical International Ltd., the Chief Executive Officer & Director at Mainstay Medical Ltd., the Chief Executive Officer & Director at Mainstay Medical Holdings Plc, and an Independent Director at Orthofix Medical, Inc. He previously served as an Independent Non-Executive Director at Kuros Biosciences Ltd.
and Sequana Medical NV.
From 2016 to 2017, he was the President & Chief Operating Officer at NuVasive, Inc. and prior to that, he held the position of Executive Vice President-International at NuVasive Netherlands BV.
Mr. Hannon completed his undergraduate studies at the University of California, Berkeley and obtained a graduate degree from Stanford Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ORTHOFIX MEDICAL, INC.
0,01% | 22.04.2024 | 3 574 ( 0,01% ) | 46 819 $ | 30.04.2024 |
Aktive Positionen von Jason M. Hannon
| Unternehmen | Position | Beginn |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Vorstandsvorsitzender | 09.10.2017 |
| ORTHOFIX MEDICAL INC. | Direktor/Vorstandsmitglied | 08.06.2020 |
Mainstay Medical Ltd.
 Mainstay Medical Ltd. Medical SpecialtiesHealth Technology Mainstay Medical Ltd. operates as a medical device company which develops neuro-stimulation therapies for people with debilitating chronic low back pain. It develops ReActiv8, an active implantable medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in Dublin, Ireland. | Vorstandsvorsitzender | - |
Mainstay Medical Holdings Plc
 Mainstay Medical Holdings Plc Financial ConglomeratesFinance Mainstay Medical Holdings Plc is a medical device company, which focuses on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling mechanical Chronic Low Back Pain. The company was founded in 2020 and is headquartered in Dublin, Ireland. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Jason M. Hannon
| Unternehmen | Position | Ende |
|---|---|---|
| NUVASIVE, INC. | Präsident | 01.08.2017 |
| SEQUANA MEDICAL N.V. | Direktor/Vorstandsmitglied | - |
| KUROS BIOSCIENCES AG | Direktor/Vorstandsmitglied | - |
| NuVasive Netherlands BV | Corporate Officer/Principal | - |
Ausbildung von Jason M. Hannon
| University of California, Berkeley | Undergraduate Degree |
| Stanford Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| KUROS BIOSCIENCES AG | Health Technology |
| SEQUANA MEDICAL N.V. | Health Technology |
| ORTHOFIX MEDICAL INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
| NuVasive Netherlands BV | |
Mainstay Medical International Ltd.
 Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Mainstay Medical International Ltd. is a medical device company, which is engages in the development of neurostimulation system. It focuses on the study of ReActiv8, a medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in San Diego, CA. | Health Technology |
Mainstay Medical Ltd.
Mainstay Medical Ltd. Medical SpecialtiesHealth Technology Mainstay Medical Ltd. operates as a medical device company which develops neuro-stimulation therapies for people with debilitating chronic low back pain. It develops ReActiv8, an active implantable medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Mainstay Medical Holdings Plc
Mainstay Medical Holdings Plc Financial ConglomeratesFinance Mainstay Medical Holdings Plc is a medical device company, which focuses on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling mechanical Chronic Low Back Pain. The company was founded in 2020 and is headquartered in Dublin, Ireland. | Finance |
